GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,064.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 2,208.00
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,060.41m
  • Volume: 15,705,935
  • Market Cap: £83,807m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK's cholestatic pruritus treatment Lynavoy gets US FDA approval

By Josh White

Date: Thursday 19 Mar 2026

(Sharecast News) - GSK said on Thursday that the US Food and Drug Administration has approved its drug 'Lynavoy', or linerixibat, for the treatment of cholestatic pruritus in adults with primary biliary cholangitis, marking the first approved therapy in the US for the condition.

GSK ShareCast News

FDA expands approved age indication for GSK RSV ... 13-Mar-2026 ShareCast
Transaction in Own Shares 10-Mar-2026 ShareCast
Board Committee Change 09-Mar-2026 ShareCast
GSK secures Japan and China reviews for two late... 26-Feb-2026 ShareCast
Director/PDMR Shareholding 25-Feb-2026 ShareCast

GSK Regulatory News

Transaction in Own Shares 31-Mar-2026 07:00 RNS
Bepirovirsen accepted for review in China 30-Mar-2026 07:05 RNS
Exdensur approved for severe asthma in China 30-Mar-2026 07:00 RNS
Transaction in Own Shares 30-Mar-2026 07:00 RNS
Bepirovirsen accepted for review by the EMA 27-Mar-2026 07:00 RNS

GSK Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 2,064.00p
Change Today 1.00p
% Change 0.05 %
52 Week High 2,208.00
52 Week Low 1,264.00
Volume 15,705,935
Shares Issued 4,060.41m
Market Cap £83,807m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 19-Feb-26 13-Nov-25
Paid 09-Apr-26 08-Jan-26
Amount 18.00p 16.00p

Trades for 31-Mar-2026

Time Volume / Share Price
16:19 0 @ 2,080.00p
16:19 0 @ 2,080.00p
15:23 0 @ 2,076.00p
15:23 0 @ 2,076.00p
15:23 0 @ 2,076.00p

GSK Key Personnel

CEO Luke Miels

Top of Page